Skip to main content

Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities below and streamline your search by using keyword or type of funding.

Please also check the “Other Notices” tab on the NIH Guide for Grants and Contracts to see updates to NIH policies that ensure alignment with the Administration’s priorities.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Highlighted Topics

Topic Title	Close Date	Program Official
Advancing Nanotechnology Research to Improve Diagnosis and Treatment Options	March 10, 2028	Indu Kohaar, Ph.D. Sidney Fu, M.D.
Advancing Toward a Cure for Acquired Neuropathy	April 6, 2028	Rachel Altshuler, Ph.D.
Advancing Mechanism-driven Translational Research of Beneficial and Detrimental Effect of Psilocybin on Cancer and Other Health Conditions	April 10, 2028	Rachel Altshuler, Ph.D.
GLP-1s: Implications for Nutritional Status and Metabolic Health	April 24, 2028	Edward Sauter, M.D., Ph.D.
Unexplained Anemia in Older Persons: Elucidating Etiologies, Improving Diagnoses, and Identifying and Testing Potential Treatment Strategies	May 11, 2028	Young Kim, Ph.D.
Enhancing Data Usage and Utility to Advance Biomedical Research	June 24, 2028	Wendy Wang, Ph.D.
Research on the Role of Post-Translational Modifications in Human Health and Disease (Biomarkers)	June 26, 2028	Nicolas Hodges, Ph.D.
New approach methodologies for dietary supplement and nutrition research	May 20, 2028	Nancy Emenaker, Ph.D., RDN
Food is Medicine	June 3, 2028	Young Kim, Ph.D.

Notice of Funding Opportunities

Title	Announcement Number	Activity Code	Clinical Trials Status	Expiration Date Sort descending	Program Official
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes	PAR-25-095 (R01 Clinical Trial Not Allowed)	R01	Clinical Trial Not Allowed	09/07/2026	Wendy Wang, Ph.D., M.Sc.
NCI Community Oncology Research Program (NCORP) Academic Community Sites	RFA-CA-27-008 (UG1 Clinical Trials Not Allowed)	UG1		09/18/2026	Brandy Heckman-Stoddard, Ph.D., M.P.H.
NCI Community Oncology Research Program (NCORP) Research Bases	RFA-CA-27-006 (UG1 Clinical Trial Required)	UG1	Clinical Trial Required	09/18/2026	Brandy Heckman-Stoddard, Ph.D., M.P.H.
NCI Community Oncology Research Program (NCORP) Community Sites	RFA-CA-27-007 (UG1 Clinical Trial Not Allowed)	UG1	Clinical Trial Not Allowed	09/18/2026	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Assay Validation of High Quality Markers for Clinical Studies in Cancer	PAR-25-074 (UH2/UH3 Clinical Trial Not Allowed)	UH2, UH3	Clinical Trial Not Allowed	10/14/2026	Sudhir Srivastava, Ph.D., M.P.H.
Assay Validation of High Quality Markers for Clinical Studies in Cancer	PAR-25-075 (UH3 Clinical Trials Not Allowed)	UH3		10/14/2026	Sudhir Srivastava, Ph.D., M.P.H.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers	PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed)	R00, K99	Clinical Trial Not Allowed	10/15/2026	Asad Umar, D.V.M., Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers	PAR-23-287 (K99/R00 - Independent Clinical Trial Required)	R00, K99	Clinical Trial Required	10/15/2026	Asad Umar, D.V.M., Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers	PAR-23-288 (K99/R00 - Independent Basic Experimental Studies with Humans Required)	R00, K99		10/15/2026	Asad Umar, D.V.M., Ph.D.
Cancer Prevention and Control Clinical Trials Grant Program	PAR-25-167 (R01 Clinical Trial Required)	R01	Clinical Trial Required	01/07/2027	Goli Samimi, Ph.D., M.P.H.